secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stoke Therapeutics, Inc. (STOK)
CIK:        0001623526
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001193125-23-264160
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stoke Therapeutics shareholders approve option exchange for RSUs at special meeting
--------------------------------------------------------------------------------

- Stockholders voted 23,393,135 For, 8,352,191 Against, 26,577 Abstained on proposal.
- Approved one-time value-neutral exchange of outstanding employee stock options for restricted stock units.
- Exchange applies to options under 2014 and 2019 Equity Incentive Plans held by eligible employees.
- Proposal was described as approximately value neutral for shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1623526/000119312523264160/0001193125-23-264160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1623526/000119312523264160/d562135d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-264160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer